Created in 2003, Horus Pharma stands out as an independent French player in the pharmaceutical industry, specializing in ophthalmology . Entering boldly into the European space, since its launch, it has played a pioneering role in the development of formulations and products without preservatives , and has subsequently extended its expertise to dermatology and cosmetics.
In addition to ophthalmology, since 2003, Horus Pharma has been developing, patenting and marketing products for eye and eyelid health . Operating in most segments related to ophthalmology, Horus Pharma excels in the development of pragmatic innovations that combine efficacy and safety.
Prioritizing patient safety, the laboratory has acquired recognized expertise in the development of effective solutions and product ranges without preservatives.
Throughout their career in ophthalmology, the founders of the laboratory have developed a solid conviction of which Horus Pharma is the main standard bearer: " Microbiological quality can be perfectly ensured without resorting to preservatives, whose deleterious effects are recognized."
The Horus Pharma laboratory is distinguished by its development, patenting and marketing of products specifically dedicated to eye and eyelid health . It is positioning itself boldly in many segments related to ophthalmology, propelling innovations that merge efficacy and safety .
Horus Pharma offers a wide range of products, including drugs, medical devices and dietary supplements. A recently added surgical division further enriches their catalog. This division enables the brand to pursue its innovation by offering effective solutions for surgery, peri-surgery, and aid in the diagnosis of ocular pathologies.
Horus Pharma offers a variety of products for the treatment of ocular allergy , inflammation, corneal edema, cataracts, and many others. In their dermatological range , the laboratory provides products such as wipes to soothe pathological eyelids and gel in case of acne lesions. Dedicated lens care devices are also available for optimal vision and increased comfort.
Horus Pharma is committed to a policy in favor of the quality of promotional information, scrupulously respecting the rules of ethics stipulated by the Charter of information by canvassing or prospecting aimed at the promotion of medicines.
The pharmaceutical company Horus Pharma has been certified by the independent organization AB certification , in accordance with the HAS certification reference system of March 2017, for its information activity by canvassing or prospecting aimed at promoting medicines.
The Horus Pharma laboratory is committed to a quality policy in terms of promotional information. For more information, consult the online documentation: information charter by canvassing or prospecting aimed at promoting medicinal products.
Beyond the formulation, the challenge also lies in the continuous improvement of health products thanks to a permanent questioning of all the other elements: the galenic, the administration device and the manufacturing processes.
Horus Pharma, with several patents to its credit, works daily to follow its guideline: to provide innovative solutions in response to the needs of doctors and for the benefit of patients.
